Searcharxiv⌕ Search

arXiv subjects

Ashkan Ertefaie

Publications and source records attributed to Ashkan Ertefaie.

31 records · Page 2Linked to original sources

Selective inference for effect modification via the lasso

Effect modification occurs when the effect of the treatment on an outcome varies according to the level of other covariates and often has important implications in decision making. When there are tens or hundreds of covariates, it becomes necessary to use the observed data to select a simpler model for effect modification and then make valid statistical inference. We propose a two stage procedure to solve this problem. First, we use Robinson's transformation to decouple the nuisance parameters from the treatment effect of interest and use machine learning algorithms to estimate the nuisance parameters. Next, after plugging in the estimates of the nuisance parameters, we use the Lasso to choose a low-complexity model for effect modification. Compared to a full model consisting of all the covariates, the selected model is much more interpretable. Compared to the univariate subgroup analyses, the selected model greatly reduces the number of false discoveries. We show that the conditional selective inference for the selected model is asymptotically valid given the rate assumptions in classical semiparametric regression. Extensive simulation studies are conducted to verify the asymptotic results and an epidemiological application is used to demonstrate the method.

stat.ME↗

Instrumented Difference-in-Differences

Unmeasured confounding is a key threat to reliable causal inference based on observational studies. Motivated from two powerful natural experiment devices, the instrumental variables and difference-in-differences, we propose a new method called instrumented difference-in-differences that explicitly leverages exogenous randomness in an exposure trend to estimate the average and conditional average treatment effect in the presence of unmeasured confounding. We develop the identification assumptions using the potential outcomes framework. We propose a Wald estimator and a class of multiply robust and efficient semiparametric estimators, with provable consistency and asymptotic normality. In addition, we extend the instrumented difference-in-differences to a two-sample design to facilitate investigations of delayed treatment effect and provide a measure of weak identification. We demonstrate our results in simulated and real datasets.

stat.ME↗

A non-parametric Bayesian approach for adjusting partial compliance in sequential decision making

Existing methods in estimating the mean outcome under a given dynamic treatment regime rely on intention-to-treat analyses which estimate the effect of following a certain dynamic treatment regime regardless of compliance behavior of patients. There are two major concerns with intention-to-treat analyses: (1) the estimated effects are often biased toward the null effect; (2) the results are not generalizable and reproducible due to the potential differential compliance behavior. These are particularly problematic in settings with high level of non-compliance such as substance use disorder treatments. Our work is motivated by the Adaptive Treatment for Alcohol and Cocaine Dependence study (ENGAGE), which is a multi-stage trial that aimed to construct optimal treatment strategies to engage patients in therapy. Due to the relatively low level of compliance in this trial, intention-to-treat analyses essentially estimate the effect of being randomized to a certain treatment sequence which is not of interest. We fill this important gap by defining the target parameter as the mean outcome under a dynamic treatment regime given potential compliance strata. We propose a flexible non-parametric Bayesian approach, which consists of a Gaussian copula model for the potential compliances, and a Dirichlet process mixture model for the potential outcomes. Our simulations highlight the need for and usefulness of this approach in practice and illustrate the robustness of our estimator in non-linear and non-Gaussian settings.

stat.ME↗

Nonparametric inverse probability weighted estimators based on the highly adaptive lasso

Inverse probability weighted estimators are the oldest and potentially most commonly used class of procedures for the estimation of causal effects. By adjusting for selection biases via a weighting mechanism, these procedures estimate an effect of interest by constructing a pseudo-population in which selection biases are eliminated. Despite their ease of use, these estimators require the correct specification of a model for the weighting mechanism, are known to be inefficient, and suffer from the curse of dimensionality. We propose a class of nonparametric inverse probability weighted estimators in which the weighting mechanism is estimated via undersmoothing of the highly adaptive lasso, a nonparametric regression function proven to converge at $n^{-1/3}$-rate to the true weighting mechanism. We demonstrate that our estimators are asymptotically linear with variance converging to the nonparametric efficiency bound. Unlike doubly robust estimators, our procedures require neither derivation of the efficient influence function nor specification of the conditional outcome model. Our theoretical developments have broad implications for the construction of efficient inverse probability weighted estimators in large statistical models and a variety of problem settings. We assess the practical performance of our estimators in simulation studies and demonstrate use of our proposed methodology with data from a large-scale epidemiologic study.

stat.ME↗

Bayesian Set of Best Dynamic Treatment Regimes and Sample Size Determination for SMARTs with Binary Outcomes

One of the main goals of sequential, multiple assignment, randomized trials (SMART) is to find the most efficacious design embedded dynamic treatment regimes. The analysis method known as multiple comparisons with the best (MCB) allows comparison between dynamic treatment regimes and identification of a set of optimal regimes in the frequentist setting for continuous outcomes, thereby, directly addressing the main goal of a SMART. In this paper, we develop a Bayesian generalization to MCB for SMARTs with binary outcomes. Furthermore, we show how to choose the sample size so that the inferior embedded DTRs are screened out with a specified power. We compare log-odds between different DTRs using their exact distribution without relying on asymptotic normality in either the analysis or the power calculation. We conduct extensive simulation studies under two SMART designs and illustrate our method's application to the Adaptive Treatment for Alcohol and Cocaine Dependence (ENGAGE) trial.

stat.ME↗

Adjusting for Partial Compliance in SMARTs: a Bayesian Semiparametric Approach

The cyclical and heterogeneous nature of many substance use disorders highlights the need to adapt the type or the dose of treatment to accommodate the specific and changing needs of individuals. The Adaptive Treatment for Alcohol and Cocaine Dependence study (ENGAGE) is a multi-stage randomized trial that aimed to provide longitudinal data for constructing treatment strategies to improve patients' engagement in therapy. However, the high rate of noncompliance and lack of analytic tools to account for noncompliance have impeded researchers from using the data to achieve the main goal of the trial. We overcome this issue by defining our target parameter as the mean outcome under different treatment strategies for given potential compliance strata and propose a Bayesian semiparametric model to estimate this quantity. While it adds substantial complexities to the analysis, one important feature of our work is that we consider partial rather than binary compliance classes which is more relevant in longitudinal studies. We assess the performance of our method through comprehensive simulation studies. We illustrate its application on the ENGAGE study and demonstrate that the optimal treatment strategy depends on compliance strata.

stat.ME↗

Robust Q-learning

Q-learning is a regression-based approach that is widely used to formalize the development of an optimal dynamic treatment strategy. Finite dimensional working models are typically used to estimate certain nuisance parameters, and misspecification of these working models can result in residual confounding and/or efficiency loss. We propose a robust Q-learning approach which allows estimating such nuisance parameters using data-adaptive techniques. We study the asymptotic behavior of our estimators and provide simulation studies that highlight the need for and usefulness of the proposed method in practice. We use the data from the "Extending Treatment Effectiveness of Naltrexone" multi-stage randomized trial to illustrate our proposed methods.

stat.ME↗

Power Analysis in a SMART Design: Sample Size Estimation for Determining the Best Dynamic Treatment Regime

Sequential, multiple assignment, randomized trial (SMART) designs have become increasingly popular in the field of precision medicine by providing a means for comparing sequences of treatments tailored to the individual patient, i.e., dynamic treatment regime (DTR). The construction of evidence-based DTRs promises a replacement to adhoc one-size-fits-all decisions pervasive in patient care. However, there are substantial statistical challenges in sizing SMART designs due to the complex correlation structure between the DTRs embedded in the design. Since the primary goal of SMARTs is the construction of an optimal DTR, investigators are interested in sizing SMARTs based on the ability to screen out DTRs inferior to the optimal DTR by a given amount which cannot be done using existing methods. In this paper, we fill this gap by developing a rigorous power analysis framework that leverages multiple comparisons with the best methodology. Our method employs Monte Carlo simulation in order to compute the minimum number of individuals to enroll in an arbitrary SMART. We will evaluate our method through extensive simulation studies. We will illustrate our method by retrospectively computing the power in the Extending Treatment Effectiveness of Naltrexone SMART study.

stat.AP↗

Variable Selection in Causal Inference using a Simultaneous Penalization Method

In the causal adjustment setting, variable selection techniques based on one of either the outcome or treatment allocation model can result in the omission of confounders, which leads to bias, or the inclusion of spurious variables, which leads to variance inflation, in the propensity score. We propose a variable selection method based on a penalized objective function which considers the outcome and treatment assignment models simultaneously. The proposed method facilitates confounder selection in high-dimensional settings. We show that under regularity conditions our method attains the oracle property. The selected variables are used to form a doubly robust regression estimator of the treatment effect. We show that under some conditions our method attains the oracle property. Simulation results are presented and economic growth data are analyzed. Specifically, we study the effect of life expectancy as a measure of population health on the average growth rate of gross domestic product per capita.

stat.ME↗

Constructing Dynamic Treatment Regimes in Infinite-Horizon Settings

The application of existing methods for constructing optimal dynamic treatment regimes is limited to cases where investigators are interested in optimizing a utility function over a fixed period of time (finite horizon). In this manuscript, we develop an inferential procedure based on temporal difference residuals for optimal dynamic treatment regimes in infinite-horizon settings, where there is no a priori fixed end of follow-up point. The proposed method can be used to determine the optimal regime in chronic diseases where patients are monitored and treated throughout their life. We derive large sample results necessary for conducting inference. We also simulate a cohort of patients with diabetes to mimic the third wave of the National Health and Nutrition Examination Survey, and we examine the performance of the proposed method in controlling the level of hemoglobin A1c. Supplementary materials for this article are available online.

stat.ME↗

Selection bias when using instrumental variable methods to compare two treatments but more than two treatments are available

Instrumental variable (IV) methods are widely used to adjust for the bias in estimating treatment effects caused by unmeasured confounders in observational studies. In this manuscript, we provide empirical and theoretical evidence that the IV methods may result in biased treatment effects if applied on a data set in which subjects are preselected based on their received treatments. We frame this as a selection bias problem and propose a procedure that identifies the treatment effect of interest as a function of a vector of sensitivity parameters. We also list assumptions under which analyzing the preselected data does not lead to a biased treatment effect estimate. The performance of the proposed method is examined using simulation studies. We applied our method on The Health Improvement Network (THIN) database to estimate the comparative effect of metformin and sulfonylureas on weight gain among diabetic patients.

stat.ME↗

Variable Selection in Causal Inference Using Penalization

In the causal adjustment setting, variable selection techniques based on either the outcome or treatment allocation model can result in the omission of confounders or the inclusion of spurious variables in the propensity score. We propose a variable selection method based on a penalized likelihood which considers the response and treatment assignment models simultaneously. The proposed method facilitates confounder selection in high-dimensional settings. We show that under some conditions our method attains the oracle property. The selected variables are used to form a double robust regression estimator of the treatment effect. Simulation results are presented and economic growth data are analyzed.

math.ST↗

The Propensity Score Estimation in the Presence of Length-biased Sampling: A Nonparametric Adjustment Approach

The pervasive use of prevalent cohort studies on disease duration, increasingly calls for appropriate methodologies to account for the biases that invariably accompany samples formed by such data. It is well-known, for example, that subjects with shorter lifetime are less likely to be present in such studies. Moreover, certain covariate values could be preferentially selected into the sample, being linked to the long-term survivors. The existing methodology for estimation of the propensity score using data collected on prevalent cases requires the correct conditional survival/hazard function given the treatment and covariates. This requirement can be alleviated if the disease under study has stationary incidence, the so-called stationarity assumption. We propose a nonparametric adjustment technique based on a weighted estimating equation for estimating the propensity score which does not require modeling the conditional survival/hazard function when the stationarity assumption holds. Large sample properties of the estimator is established and its small sample behavior is studied via simulation.

math.ST↗